MLLTS trial
Phase 2
- Conditions
- lymphangioleiomyomatosis
- Registration Number
- JPRN-jRCT1091220037
- Lead Sponsor
- Koh Nakata, MD, Ph.D
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- OTHER
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
1. LAM patients with definitive diagnosis.
2. patients who is expected to live more than two years.
3. patients who can visit out patient clinic periodically.
4. patients from whom a written informed consent will be obtained.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All adverse events
- Secondary Outcome Measures
Name Time Method 1, adverse events<br>2, walk distance of 6MT<br>3, pulmonary function test<br>4, frequency of pneumothorax or amount of effusion of chylothorax